{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:53:34Z","timestamp":1792511614988,"version":"4.5.0"},"reference-count":36,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Preeclampsia (PE) is a pregnancy-related disorder that significantly increases the risk of maternal and fetal morbidity and mortality. Melatonin, a potent antioxidant, has been suggested to mitigate oxidative stress and associated damage in various pathological conditions. Placental growth factor (PlGF) plays a vital role in placental development by promoting angiogenesis. This study aimed to investigate whether the levels of melatonin, cytokines, and PlGF were higher in the venous blood of women with preeclampsia during the third trimester of pregnancy compared to those with uncomplicated pregnancies. The study involved 32 women with preeclampsia and 33 healthy pregnant women as a control group. The concentrations of melatonin and PlGF were significantly lower in women with preeclampsia compared to healthy pregnant women. Specifically, the mean level of melatonin in the preeclampsia group was 30.98 pg\/ml and 55.20 pg\/ml in the control group (p=0.029). Similarly, the mean level of PlGF in the preeclampsia group was 40.03 pg\/ml and 213.31 pg\/ml in the control group (p&lt;0.0001). This suggests that alterations in the placental production of melatonin and PlGF may contribute to the development of preeclampsia. In contrast, we observed higher levels of the pro-inflammatory cytokine interleukin-6 (IL-6) and the anti-inflammatory cytokine interleukin-10 (IL-10) in the preeclampsia group than in the control group. The mean concentration of IL-6 in the PE group was 270.79 pg\/ml, whereas the control group had 224.30 pg\/ml (p=0.022). Similarly, the mean concentration of IL-10 in the PE group was 41.90 pg\/ml and 30.73 pg\/ml in the control group (p=0.018). In women with uncomplicated pregnancies, the interaction between pro-inflammatory interleukine-6 and melatonin can be described by equality of statistical regression.<\/jats:p>","DOI":"10.25122\/jml-2022-0283","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:33:17Z","timestamp":1683513197000},"page":"471-476","source":"Crossref","is-referenced-by-count":11,"title":["Changes in concentrations of melatonin, PlGF, and cytokines in women with preeclampsia"],"prefix":"10.25122","volume":"16","author":[{"given":"Ruslan Florovych","family":"Savka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"* Corresponding Author: Ruslan Florovych Savka, Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine. E-mail: savcaruslan@gmail.com","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrii Mykolaiovych","family":"Berbets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Mykhailovych Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Mykhailovych Yuzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Obstetrics and Gynecology, Bukovinian State Medical University, Chernivtsi, Ukraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela Raluca","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Materno-Fetal Assistance Excellence Unit, Polizu Clinical Hospital, Alessandrescu-Rusescu National Institute for Mother and Child Health, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Langston-Cox A, Marshall SA, Lu D, Palmer KR, Wallace EM. Melatonin for the Management of Preeclampsia: A Review. Antioxidants (Basel). 2021;10(3):376. doi:10.3390\/antiox10030376.","DOI":"10.3390\/antiox10030376"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Lowe SA, Bowyer L, Lust K, McMahon LP,\n                      et al.\n                      SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust. N. Z. J. Obstet. Gynaecol. 2015;55:e1\u2013e29. doi: 10.1111\/ajo.12399.","DOI":"10.1111\/ajo.12399"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Sahu MB, Deepak V, Gonzales SK, Rimawi B,\n                      et al.\n                      Decidual cells from women with preeclampsia exhibit inadequate decidualization and reduced sFlt1 suppression. Pregnancy Hypertens. 2019 Jan;15:64-71. doi: 10.1016\/j. preghy.2018.11.003.","DOI":"10.1016\/j.preghy.2018.11.003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011 Jan;31(1):33-46. doi: 10.1016\/j.semnephrol.2010.10.004.","DOI":"10.1016\/j.semnephrol.2010.10.004"},{"key":"ref5","unstructured":"5. Udenze I, Amadi C, Awolola N, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015 Mar 10;20:219. doi: 10.11604\/pamj.2015.20.219.5317."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Aggarwal R, Jain AK, Mittal P, Kohli M,\n                      et al.\n                      Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019 May;33(4):e22834. doi: 10.1002\/jcla.22834.","DOI":"10.1002\/jcla.22834"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1315-F1326. doi: 10.1152\/ajprenal.00071.2020.","DOI":"10.1152\/ajprenal.00071.2020"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet. 1999 Sep 4;354(9181):788-9. doi: 10.1016\/S0140-6736(99)80002-6.","DOI":"10.1016\/S0140-6736(99)80002-6"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Marseglia L, D'Angelo G, Manti S, Reiter RJ, Gitto E. Potential Utility of Melatonin in Preeclampsia, Intrauterine Fetal Growth Retardation, and Perinatal Asphyxia. Reprod Sci. 2016 Aug;23(8):970-7. doi: 10.1177\/1933719115612132.","DOI":"10.1177\/1933719115612132"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Richter HG, Hansell JA, Raut S, Giussani DA. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res. 2009;46:357-64.","DOI":"10.1111\/j.1600-079X.2009.00671.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Nakamura Y, Tamura H, Kashida S, Takayama H,\n                      et al.\n                      Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001 Jan;30(1):29-33. doi: 10.1034\/j.1600-079x.2001.300104.x.","DOI":"10.1034\/j.1600-079X.2001.300104.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Olcese J, Beesley S. Clinical significance of melatonin receptors in the human myometrium. Fertil Steril. 2014 Aug;102(2):329-35. doi: 10.1016\/j. fertnstert.2014.06.020.","DOI":"10.1016\/j.fertnstert.2014.06.020"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Dou Y, Lin B, Cheng H, Wang C,\n                      et al.\n                      The reduction of melatonin levels is associated with the development of preeclampsia: a meta-analysis. Hypertens Pregnancy. 2019 May;38(2):65-72. doi: 10.1080\/10641955.2019.1581215.","DOI":"10.1080\/10641955.2019.1581215"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Berbets A, Davydenko I, Barbe A, Konkov D,\n                      et al.\n                      Melatonin 1A and 1B Receptors\u2019 Expression Decreases in the Placenta of Women with Fetal Growth Restriction. Reprod Sci. 2020;28:197-206.","DOI":"10.1007\/s43032-020-00285-5"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Venkatesha S, Toporsian M, Lam C, Hanai J,\n                      et al.\n                      Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038\/nm1429.","DOI":"10.1038\/nm1429"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Rana S, Karumanchi SA, Levine RJ, Venkatesha S,\n                      et al.\n                      Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007 Jul;50(1):137-42. doi: 10.1161\/ HYPERTENSIONAHA.107.087700.","DOI":"10.1161\/HYPERTENSIONAHA.107.087700"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Lu F, Longo M, Tamayo E, Maner W,\n                      et al.\n                      The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am. J. Obstet. Gynecol. 2007;196:e1\u2013e7. doi: 10.1016\/j.ajog.2006.12.024.","DOI":"10.1016\/j.ajog.2006.12.024"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Maynard SE, Min JY, Merchan J, Lim KH,\n                      et al.\n                      Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Investig. 2003;111:649\u2013658. doi: 10.1172\/JCI17189.","DOI":"10.1172\/JCI17189"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Hobson SR, Acharya R, Lim R, Chan ST,\n                      et al.\n                      Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. Pregnancy Hypertens. 2016 Apr;6(2):130-3. doi: 10.1016\/j.preghy.2016.03.001.","DOI":"10.1016\/j.preghy.2016.03.001"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Lanoix D, Guerin P, Vaillancourt C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: New insights into the role of this hormone in pregnancy. J. Pineal Res. 2012;53:417\u2013425. doi: 10.1111\/j.1600-079X.2012.01012.x.","DOI":"10.1111\/j.1600-079X.2012.01012.x"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Aggarwal R, Jain AK, Mittal P, Kohli M,\n                      et al.\n                      Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019 May;33(4):e22834. doi: 10.1002\/jcla.22834.","DOI":"10.1002\/jcla.22834"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Liu X, Gong Y, Xiong K, Ye Y,\n                      et al.\n                      Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res. 2013;55(1):14-25.","DOI":"10.1111\/jpi.12045"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Chen SJ, Huang SH, Chen JW, Wang KC,\n                      et al.\n                      Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2016;31:169-77.","DOI":"10.1016\/j.intimp.2015.12.020"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Berbets AM, Barbe AM, Andriiets OA, Andriiets AV, Yuzko OM. Melatonin Levels Decrease in the Umbilical Cord in Case of Intrauterine Growth Restriction. J Med Life. 2020 Oct-Dec;13(4):548-553. doi: 10.25122\/jml-2020-0128.","DOI":"10.25122\/jml-2020-0128"},{"key":"ref25","unstructured":"25. Phyllis A, Baha MS. Preeclampsia: Clinical features and diagnosis. Available from: https:\/\/www.uptodate.com\/contents\/preeclampsia-clinical-featuresand-diagnosis"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Chiarello DI, Abad C, Rojas D, Toledo F,\n                      et al.\n                      Oxidative stress: Normal pregnancy versus preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2020 Feb 1;1866(2):165354. doi: 10.1016\/j.bbadis.2018.12.005.","DOI":"10.1016\/j.bbadis.2018.12.005"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Han KA, Patel Y, Lteif AA, Chisholm R, Mather KJ. Contributions of dysglycaemia, obesity, and insulin resistance to impaired endotheliumdependent vasodilation in humans. Diabetes Metab Res Rev. 2011 May;27(4):354-61. doi: 10.1002\/dmrr.1183.","DOI":"10.1002\/dmrr.1183"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Ichikawa H, Kokura S, Aw TY. Role of endothelial mitochondria in oxidant production and modulation of neutrophil adherence. J Vasc Res. 2004 Sep-Oct;41(5):432-44. doi: 10.1159\/000081466.","DOI":"10.1159\/000081466"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review. Placenta. 2003 Apr;24 Suppl A:S21-7. doi: 10.1053\/plac.2002.0930.","DOI":"10.1053\/plac.2002.0930"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol. 2001 Oct;98(4):608-11. doi: 10.1016\/s0029-7844(01)01528-9.","DOI":"10.1097\/00006250-200110000-00015"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Luttun A, Tjwa M, Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci. 2002;979:80\u201393. doi: 10.1111\/j.1749-6632.2002.tb04870.","DOI":"10.1111\/j.1749-6632.2002.tb04870.x"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Wang Y, Gu Y, Alexander JS, Lewis DF. Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses. Pathophysiology. 2021 Apr 8;28(2):202-211. doi: 10.3390\/pathophysiology28020013.","DOI":"10.3390\/pathophysiology28020013"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Harmon A, Cornelius D, Amaral L, Paige A,\n                      et al.\n                      IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia. Hypertens. 2015;34(3):291\u2013306. doi: 10.3109\/10641955.2015.1032054.","DOI":"10.3109\/10641955.2015.1032054"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Cubro H, Kashyap S, Nath MC, Ackerman AW, Garovic VD. The Role of Interleukin-10 in the Pathophysiology of Preeclampsia. Curr Hypertens Rep. 2018 Apr 30;20(4):36. doi: 10.1007\/s11906-018-0833-7.","DOI":"10.1007\/s11906-018-0833-7"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Rijhsinghani AG, Thompson K, Tygrette L, Bhatia SK. Inhibition of interleukin-10 during pregnancy results in neonatal growth retardation. Am J Reprod Immunol. 1997;37(3):232\u20135.","DOI":"10.1111\/j.1600-0897.1997.tb00220.x"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Ferguson KK, Meeker JD, McElrath TF, Mukherjee B, Cantonwine DE. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnan- cies. American Journal of Obstetrics and Gynecology. 2017;216(5):527.e1\u20139. https:\/\/doi.org\/10.1016\/ j.ajog.2016.12.","DOI":"10.1016\/j.ajog.2016.12.174"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/23.-jml-2022-0283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:33:27Z","timestamp":1683513207000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/23.-jml-2022-0283.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["JMedLife-16-471"],"URL":"https:\/\/doi.org\/10.25122\/jml-2022-0283","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}